Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats

Brain Research

Volumn 787, Issue 2, 1998, Pages 286-291

  Attwell, P J E ^a   Koumentaki, A ^a   Croucher, M J ^b   Bradford, H F ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Division Psychology   (United Kingdom)

Author keywords

2 R,4R APDC; Anticonvulsant; Epileptogenesis; Glutamate; Group II metabotropic glutamate receptor; Kindling

Indexed keywords

4 AMINOPYRROLIDINE 2,4 DICARBOXYLATE; AMINO ACID RECEPTOR STIMULATING AGENT; ASPARTIC ACID; METABOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; EPILEPSY; INTRACEREBRAL DRUG ADMINISTRATION; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE THRESHOLD;

ANIMALS; ANTICONVULSANTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; KINDLING, NEUROLOGIC; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPTOSOMES;

EID: 0032559872     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01500-X     Document Type: Article

References (39)

1. Abdul-Ghani A-S., Attwell P.J.E., Singh Kent N., Bradford H.F., Croucher M.J., Jane D.E. Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Res. 755:1997;202-212.
2. Attwell P.J.E., Kaura S., Sigala G., Bradford H.F., Croucher M.J., Jane D.E., Watkins J.C. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res. 698:1995;155-162.
3. Bradford H.F. Glutamate, GABA and epilepsy. Prog. Neurobiol. 47:1995;477-511.
4. Bradford H.F. Basic neurochemical mechanisms of the epilepsies. Int. Med. J. 3:1996;183-198.
5. Chapman A.G., Graham J.L., Meldrum B.S. Potent oral anticonvulsant activity of CPP and CPPene in DBA/2 mice. Eur. J. Pharmacol. 178:1990;97-99.
6. Coutinho-Netto J., Abdul-Ghani A.S., Collins J.F., Bradford H.F. Is glutamate a trigger factor in epileptic hyperactivity? Epilepsia. 22:1981;289-296.
7. Croucher M.J., Bradford H.F. Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into rat amygdala. Brain Res. 501:1989;58-65.
8. Croucher M.J., Bradford H.F. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala. Brain Res. 506:1990;349-352.
9. Croucher M.J., Collins J.F., Meldrum B.S. Anticonvulsant action of excitatory amino acid antagonists. Science. 216:1982;899-901.
10. Croucher M.J., Cotterell K.L., Bradford H.F. Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling. Eur. J. Pharmacol. 286:1995;265-271.
11. Croucher M.J., Cotterell K.L., Bradford H.F. Competitive NMDA receptor antagonists raise electrically kindled seizure thresholds. Neurochem. Res. 17:1992;409-413.
12. Croucher M.J., Bradford H.F., Sunter D.C., Watkins J.C. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur. J. Pharmacol. 152:1988;28-38.
13. De Sarro G., De Sarro A. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats. Eur. J. Pharmacol. 215:1992;221-229.
14. De Sarro G., De Sarro A. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene. Neuropharmacology. 32:1993;51-58.
15. Dodd P.R., Bradford H.F. Release of amino acids from the maturing cobalt-induced epileptic focus. Brain Res. 111:1976;377-388.
16. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in conscious human brain. Lancet. 341:1993;1607-1610.
17. Dürmuller N., Craggs M., Meldrum B.S. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 17:1994;167-174.
18. Gilbert M.E. The NMDA-receptor antagonist MK-801 suppresses limbic kindling and kindled seizures. Brain Res. 463:1988;90-99.
19. Hughes P.D., Foley P., Bradford H.F., Ghatei M., Khandanian N., Bloom S.R., Wu J.Y. The differential release of amino acids and neuropeptides from purified subpopulations of mammalian GABAergic and cholinergic cerebrocortical synaptosomes. Neurochem. Res. 18:1993;393-400.
20. Kaura S., Croucher M.J., Bradford H.F., Sunter D.C., Watkins J.C. Relative anticonvulsant potencies of CPP and some novel analogues in the kindled rat. Biochem. Soc. Trans. 21:1993;419S.
21. Kaura S., Bradford H.F., Young A.M.J., Croucher M.J., Hughes P.D. The effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in-vivo and in-vitro studies. J. Neurochem. 65:1995;1240-1249.
22. Koyama I. Amino acids in the cobalt-induced epileptogenic and non-epileptogenic cat's cortex. Can. J. Physiol. Pharmacol. 50:1972;740-752.
23. Meldrum B.S., Croucher M.J., Badman G., Collins J. Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci. Lett. 39:1983;101-104.
24. Miyamoto M., Ishida M., Shinozaki H. Anticonvulsant and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat. Neuroscience. 77:1997;131-140.
25. Mori N., Wada J.A. Bidirectional transfer between kindling induced by excitatory amino acids and electrical stimulation. Brain Res. 425:1987;45-48.
26. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
27. Patel S., Chapman A.G., Graham J.L., Meldrum B.S., Frey P. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Epilepsy Res. 7:1990;3-10.
28. Peterson D.W., Collins J.F., Bradford H.F. Anticonvulsant actions of amino acid antagonists against kindled hippocampal seizures. Brain Res. 311:1984;176-180.
29. Pin J.-P., Duvoisin R. Neurotransmitter receptors: I. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
30. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
31. Schoepp D.D., Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 141:1993;13-20.
32. Schoepp D.D. Novel functions for subtypes of metabotropic glutamate receptors. Neurochem. Int. 24:1994;439-449.
33. Schoepp D.D., Johnson B.G., Salhoff C.R., Valli M.J., Desai M.A., Monn J.A. Selective inhibition of forskolin-stimulated cAMP formation in the rat hippocampus by a novel mGluR agonist, 2R,4R-APDC. Neuropharmacology. 34:1995;843-850.
34. Schoepp D.D., Johnson B.G., Monn J.A. (1S,3R)-1-Aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in the neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide and inhibitory cyclic AMP-coupled mGluRs. J. Neurochem. 66:1996;1981-1985.
35. Schoepp D.D., Salhoff C.R., Wright R.A., Johnson B.G., Burnett J.P., Mayne N.G., Belagaje R., Wu S., Monn J.A. The novel mGluR agonist 2R,4R-APDC, potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between Group I and Group II receptors. Neuropharmacology. 35:1997;1661-1672.
36. Tizzano J.P., Griffey K.I., Schoepp D.D. Receptor subtypes linked to metabotropic glutamate receptor agonist-mediated limbic seizures in mice: neuroprotective agents. Ann. New York Acad. Sci. 765:1995;230-235.
37. Watkins J.C., Collingridge G.L. Phenylglycine derivatives as metabotropic glutamate receptor antagonists. Trends Pharmacol. Sci. 15:1994;333-342.
38. Williamson J.M., Lothman E.W. The effect of MK-801 on kindled seizures: implication for use and limitations as an antiepileptic drug. Ann. Neurol. 26:1989;85-90.
39. Write R.A., Schoepp D.D. Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. Eur. J. Pharmacol. 297:1996;275-282.